Class I medical devices are lower-risk devices whose safety and effectiveness can be ensured through routine management, and they are subject to filing management — filings with complete and compliant documentation are accepted without a registration review or approval step. Overseas filers submit their filing documentation to the National Medical Products Administration (NMPA) through the filing platform. "Fast" does not mean "easy": this page compiles the complete documentation checklist and content requirements from current regulatory requirements, so you can prepare everything right the first time.
I. Filing Documentation Checklist
Class I filing documentation consists of seven items — none can be omitted:
1. Class I Medical Device Filing Form
Completed and generated through the filing platform, the filing form carries all filing information; the applicant's name, address and manufacturing address should be consistent with the supporting documents.
2. Supporting Documents (provided by the overseas filing applicant)
For overseas manufacturers, this is the focal part of preparation:
- Proof of legal status and qualifications — a document issued by the company registration authority or medical device regulatory authority in the country (region) where the overseas filing applicant is registered, demonstrating that the applicant remains legally established and possesses the relevant qualifications to manufacture the medical device; or an equivalent document issued by a third-party certification body;
- Documentation authorizing the product to be placed on the market — issued by the medical device regulatory authority in the country (region) where the overseas filing applicant is registered or where the product is manufactured. If the product is not regulated as a medical device in that country (region), the applicant shall provide relevant documentation, including a document authorizing the product to be placed on the market there; innovative medical devices not yet marketed in the applicant's country (region) may be exempt;
- China agent documents — the power of attorney designating an agent within China, the agent's undertaking letter, and a copy of the agent's business license.
3. Product Technical Requirements
Prepared in accordance with the Guidelines for Preparing Medical Device Product Technical Requirements. They shall primarily specify objectively verifiable functional and safety performance indicators of the finished device and the corresponding test methods.
4. Product Test Report
Either a full-performance self-testing report or a commissioned testing report; the tested product shall be representative of the product being filed. Photographs of the physical product shall be attached — including images of the sample after removal of all inner and outer packaging, as well as photographs of representative inner and outer packaging samples. Where multiple models or specifications are involved, photographs of a representative product shall be provided.
5. Draft Instructions for Use and Labeling for the Smallest Sales Unit
Instructions for use and labeling shall comply with the Provisions for the Administration of Medical Device Instructions for Use and Labels, the Guidelines for Preparing Instructions for Use of In Vitro Diagnostic Reagents, and other applicable requirements. Product performance described in the instructions shall be consistent with the corresponding content in the Product Technical Requirements. For imported products, the original-language instructions approved or recognized by the competent authority of the country of origin shall be submitted together with their Chinese translations.
6. Manufacturing Information
An overview of the relevant manufacturing processes: for non-active devices, the manufacturing and processing procedures shall be clearly specified with key processes identified; for active devices, descriptive documentation of the process shall be provided (a flowchart or an overview); for IVDs, the main manufacturing processes shall be summarized, including the solid-phase carrier, color development system and their rationale, plus the reaction system (sample collection and processing, sample requirements, sample volume, reagent volume, reaction conditions, calibration methods and quality control methods).
Where multiple development or manufacturing sites are involved, each site shall be summarized; where manufacturing is outsourced, the name, registered address and manufacturing address of the contracted manufacturer shall be specified.
7. Declaration of Conformity
- A declaration that the product complies with the applicable requirements for Class I filing;
- A declaration that the product meets the applicable classification requirements with supporting rationale — including the relevant provisions of the Class I Medical Device Product Catalogue or the IVD Classification Catalogue, identifying the subcatalogue and the first- and second-level product categories;
- A declaration that the product complies with current national and industry standards, with a list of applicable standards;
- A declaration that the submitted documentation is authentic and accurate (issued by the filing applicant for domestic products; issued separately by the filing applicant and the designated agent for imported products).
II. Content Requirements for the Filing Documentation
1. Product Name (Product Classification Name)
In principle, the product name (excluding IVDs) shall directly use a name listed under "Examples of Product Names" in the Class I Medical Device Product Catalogue. Where adjustment is genuinely necessary, the name shall comply with the Rules for Naming Generic Names of Medical Devices (Order No. 19 of the former CFDA) and the relevant naming guidelines. For IVDs, the classification name shall follow the IVD Classification Catalogue.
2. Product Description and Intended Use
The product description and intended use shall comply with the applicable requirements of the Class I Medical Device Product Catalogue and the IVD Classification Catalogue (the "Catalogues"), and shall not exceed the scope of descriptions, intended uses or related content specified therein.
3. Model / Specifications
Model or specification wording shall not explicitly or implicitly claim disease treatment, exaggerate the intended use, or otherwise mislead or deceive.
4. Name and Address of the Filing Applicant
For overseas filing applicants, the name, address and manufacturing address stated in the filing form shall be consistent with the supporting documents.
5. Power of Attorney and Undertaking Letter of the Designated Agent
The authorization and undertaking provisions in the power of attorney and the agent's undertaking letter shall be consistent with the filing information.
6. Instructions for Use
Content of the instructions relating to the product description — including but not limited to structural composition, main components, intended use, method of use and precautions — shall not exceed the corresponding information in the other filing documents. Where the user institution is required to sterilize or disinfect the product before use per the instructions, the instructions shall specify a validated sterilization or disinfection method.
III. Consistency: The Thread Running Through Everything
Looking across these requirements, one theme stands out: consistency. The filing form, supporting documents, product technical requirements, instructions and labels must corroborate one another — names, descriptions, composition and intended use must align without contradiction. In practice, most corrections are not about missing documents but about inconsistent wording or content exceeding the Catalogues' scope. We recommend a consistency checklist review before submission.
IV. How INTERBRI Helps
- Classification & route confirmation — assessing Class I applicability and the filing route based on intended use and composition;
- Documentation preparation & review — assembling documents against the checklist, with a focus on consistency and qualifying statements;
- Domestic agent arrangement — INTERBRI can serve as the China-domiciled agent of the overseas filer, issuing the power of attorney and undertaking letter;
- Submission & follow-up — coordinating the filing submission and progress, with prompt status updates.
Preparing a Class I filing?
Send us your product documentation — we will review the checklist and consistency, and arrange the China-agent matters for you.
About Our Class I Filing ServiceExamples of Class I medical devices in China
Class I covers lower-risk devices. Illustrative examples commonly found in the catalogue include: surgical hand instruments such as scalpels, forceps and retractors; medical gauze, bandages and cotton swabs; tongue depressors and examination gloves; X-ray film; surgical gowns and caps; and drainage bags. This list is illustrative only — the official Medical Device Classification Catalogue (and, where needed, a classification determination) decides the actual class of any specific product. If you are unsure where your product falls, see our China medical devices overview.
Class I filing vs. registration: which applies?
Whether your product is filed or registered depends entirely on its management class. Class I devices are subject to filing management: you submit compliant filing documents and the authority records them — there is no technical review or approval step, and the filing information is published within five working days under Decree No. 739, Article 15. Class II and Class III devices are subject to registration management: the application must pass acceptance, technical review and administrative approval, and the registration certificate is valid for five years. If your product is Class II or III, plan for the registration pathway — see Class II requirements and Class III requirements, or our initial registration service.
How to confirm your device’s management class
China sorts medical devices into three classes by risk. The authoritative source is the official Medical Device Classification Catalogue published by NMPA, which lists many product families together with their management class and example names. If your product is not listed, or its class is uncertain, you can apply for a classification determination (分类界定): new or unlisted products and uncertain imported products are submitted to the NMPA Standardization and Management Center, while uncertain domestic products go to the provincial authority. In practice, check the catalogue first and, where it is unclear, confirm the route with the competent authority before preparing the dossier. Our China medical devices overview and the classification catalogue guide set out the working approach.
Frequently asked questions
QHow long does a Class I filing take in China?
Under the Regulations on Supervision and Administration of Medical Devices (State Council Decree No. 739, Article 15), a filing is completed once the overseas filer submits compliant filing documents through the NMPA filing platform, and the authority publishes the filing information within five working days. That statutory step is short, but the time needed for document preparation, translation, notarisation and agent appointment beforehand is case-specific and should be planned separately. See Class I timing.
QDo overseas manufacturers need a China agent for Class I filing?
Yes. An overseas filing applicant must designate a China agent and submit the power of attorney, the agent’s undertaking letter and a copy of the agent’s business licence. Without a qualified China agent, the filing cannot be submitted. INTERBRI takes on this role — see our China Agent service.
QWhat is the difference between Class I filing and Class II/III registration?
Class I devices are subject to filing management — submissions are accepted and recorded without a technical review or approval step. Class II and Class III devices are subject to registration management and must pass acceptance, technical review and administrative approval before a registration certificate is issued; certificates are valid for five years. See Class II requirements and Class III requirements.
QCan a Class I device later be reclassified as Class II or III?
Yes. If a product’s risk profile, intended use or design changes, its management class can change, which moves it onto the registration pathway. In that case a change registration (or a fresh registration) is required — see change registration and filing.
